Which class of antiarrhythmic drugs were studied in the Cast Trial?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the RCES Exam with flashcards and multiple choice questions, each offering hints and detailed explanations. Ensure your success with a comprehensive study plan!

Multiple Choice

Which class of antiarrhythmic drugs were studied in the Cast Trial?

Explanation:
The Cast Trial examined using sodium-channel blocking antiarrhythmics (Class I), specifically the Class IC drugs flecainide and encainide, to suppress frequent premature ventricular contractions in patients with ischemic heart disease. The study found that these drugs increased mortality due to proarrhythmia, so suppressing PVCs with Class I agents in this population was harmful rather than beneficial. The trial did not address Class II, III, or IV agents, which are why those classes aren’t the focus of Cast.

The Cast Trial examined using sodium-channel blocking antiarrhythmics (Class I), specifically the Class IC drugs flecainide and encainide, to suppress frequent premature ventricular contractions in patients with ischemic heart disease. The study found that these drugs increased mortality due to proarrhythmia, so suppressing PVCs with Class I agents in this population was harmful rather than beneficial. The trial did not address Class II, III, or IV agents, which are why those classes aren’t the focus of Cast.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy